News, Policy & Media

24May

Government response to report on Brexit and medicines, medical devices and substances of human origin

Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.

Published 23 May 2018
From:
Department of Health and Social Care, Intellectual Property Office, Medicines and Healthcare products Regulatory Agency, Office for Life Sciences, and Department for Exiting the European Union
Documents

Brexit: medicines, medical devices and substances of human origin – government response to the Health and Social Care Committee's 4th report of session 2017 to 2019
 

Details
This command paper sets out the government’s response to the Health and Social Care Committee’s report following their inquiry into Brexit: medicines, medical devices and substances of human origin.

The committee published their report on 21 March 2018.

This response was prepared by the Department of Health and Social Care, in collaboration with other government departments and agencies including:

the Medicines and Healthcare products Regulatory Agency
the Office for Life Sciences
the Intellectual Property Office
the Department for Exiting the European Union
Published 23 May 2018

Related

Summary of the ask – Deadline 30 April 2018 NHSI, in conjunction with BIVDA, invite suppliers to hi...

Read More >

A major NHS England funded study is expected to almost halve the number of invasive procedures by 20...

Read More >

NHS England has committed to the long term future of England’s Academic Health Science Networks (AH...

Read More >

The briefing sessions will last for about 90 minutes. In that time you will hear and be able to disc...

Read More >

Industry proposals to help the UK’s life sciences sector become an international benchmark for succ...

Read More >

The NHS is on-track to transform cancer services in England by 2020/21 according to a report publish...

Read More >